2005•Zhejiang Journal of Integrated Traditional Chinese and Western MedicineRequires access

Treating 86 Cases of Chronic Hepatitis B with the 3rd Decoction of Kangdufugan

Chen Zhi-we

Open publisher page 0 citations

Abstract

Objective: To observe the clinical curative effect of the 3rd decoction of Kangdufugan ontreating chronic hepatitis B.Methods:Two groups both were treated with vitamin C and glucurcurolatone basically. 86 cases of therapy group were added to the 3rd decoction of Kangdufuganorally(a decoction per day), while 32 cases of control group were added to Yiganling tablets and Hugantablets.Results: The curing ratios in therapy group and control group were 21.91% and 6.25% respectively( P 0.01), the total effective ratios being 95.35% and 81.25% respect ively( P 0.05), the improvelnent ratios of major 3yndromes and symptoms being 91.07% and 67.29%. To the major indexes,there were significant difference between before and after treatment, and between the two groups after treatment.Conelusion: Kangdufugan decoction has some clinical significance in treating chronic hepatitis B, whose curative effect are better than that of Yiganling tablets with Hugan tablets.

About this research paper

What this paper is about

Objective: To observe the clinical curative effect of the 3rd decoction of Kangdufugan ontreating chronic hepatitis B.Methods:Two groups both were treated with vitamin C and glucurcurolatone basically. 86 cases of therapy group were added to the 3rd decoction of Kangdufuganorally(a decoction per day), while 32 cases of control group were added to Yiganling tablets and Hugantablets.Results: The curing ratios in therapy group and control group were 21.91% and 6.25% respectively( P 0.01), the total effective ratios being 95.35% and 81.25% respect ively( P 0.05), the improvelnent ratios of major 3yndromes and symptoms being 91.07% and 67.29%. To the major indexes,there were significant difference between before and after treatment, and between the two groups after treatment.Conelusion: Kangdufugan decoction has some clinical significance in treating chronic hepatitis B, whose curative effect are better than that of Yiganling tablets with Hugan tablets.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To observe the clinical curative effect of the 3rd decoction of Kangdufugan ontreating chronic hepatitis B.Methods:Two groups both were treated with vitamin C and glucurcurolatone basically. 86 cases of therapy group were added to the 3rd decoction of Kangdufuganorally(a decoction per day), while 32 cases of control group were added to Yiganling tablets and Hugantablets.Results: The curing ratios in therapy group and control group were 21.91% and 6.25% respectively( P 0.01), the total effective ratios being 95.35% and 81.25% respect ively( P 0.05), the improvelnent ratios of major 3yndromes and symptoms being 91.07% and 67.29%. To the major indexes,there were significant difference between before and after treatment, and between the two groups after treatment.Conelusion: Kangdufugan decoction has some clinical significance in treating chronic hepatitis B, whose curative effect are better than that of Yiganling tablets with Hugan tablets.

Key concepts: Medicine, Decoction, Chronic hepatitis, Gastroenterology, Internal medicine, Traditional medicine, Immunology, Virus

Related papers

Back to paper searchBrowse research topicsOriginal source
Treating 86 Cases of Chronic Hepatitis B with the 3rd Decoction of Kangdufugan — Research Paper | ScholarLens